Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone As Adjuvant Treatment Of Stage III Colon Cancer

NCT00026273 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00026273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone As Adjuvant Treatment Of Stage III Colon Cancer
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2001
Completion date
Not reported
Enrollment
Not reported
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer